Adcock Ingram manufactures, distributes and markets a wide range of medicines and healthcare products. Three local manufacturing sites offer significant capacity in steriles, liquids and tablet/capsule manufacturing. Adcock Ingram is thus well positioned to supply the state sector in line with the Department of Trade and Industry’s local manufacturing objectives.

Adcock Ingram has recently undertaken a capital expansion project costing R1.5 billion which was primarily focused on the regulatory compliance status of the three manufacturing facilities situated in Gauteng. The investment in the High Volume Liquids facility at Clayville has created significant capacity in liquids while expansion at the Wadeville facility has increased capacity for tablet and capsule manufacture and in particular, antiretrovirals (ARV). Adcock Ingram was awarded 25% by volume, of the South African Government ARV tender for 2013/2014.

The Company’s focus is to produce high quality pharmaceuticals in the most environmentally friendly and cost effective way by achieving operational excellence.

Adcock Ingram is taking part in the Department of Trade and Industry (DTI) Workplace Challenge initiative that has been introduced in our three local facilities. This two and a half year programme is aimed at achieving continuous improvement. The Company expects to start reaping benefits during the next two years and thereafter.

Below is a detailed summary of each of our manufacturing facilities, click on each icons to see full description on our sites:


High Volume Liquids Manufacture - Clayville
High Volume Liquids Manufacture – Clayville
High Volume Liquids
Located close to Midrand, our Clayville factory is a state of the art High Volume Liquids (HVL) facility
  • R550m upgrade with fully automated manufacturing
  • High Volume Liquids, Low Volume Liquids, effervescents and powders
  • Environmentally friendly technology - lights, water, recycling
  • Accreditation: South Africa (MCC), Ghana (FDB), Malawi (PMPB), Kenya (PPB), PIC/S and MNC
Tablet and Capsule (ARV) Manufacture - Wadeville
Tablet and Capsule (ARV) Manufacture – Wadeville
Tablet and Capsule Manufacturing
  • R240m regulatory upgrade completed
  • FDA acceptance recieved 2013
  • Further R80m upgrade will increase our tablet capacity by 50% catering for ARV and other tablet tender requirements
  • Manufactures tablets, capsules, LV liquids, creams and ointmensts
  • Accreditation: South Africa (MMC), Ghana (FDB), Botswana (DRU), Malawi (PMPB) and PIC/S
Steriles and Critical Care Manufacture - Aeroton
Steriles and Critical Care Manufacture – Aeroton
Integrated steriles manufacture, unique on the African continent
  • R330m upgrade of facility completed for regulatory compliance and capacity
  • Range of intravenous fluids, blood bags, renal dialysis products, LVPs and SVPs
  • Manufacture of medical grade sheeting for steriles and blood collection bags
  • Partner government by supplying 85% of critical care requirements to the public sector in line with PPPFA
  • Accreditation: South Africa (MCC), PIC/S ISO 9001:2008 approved
Additional Manufacturing - Bangalore
Additional Manufacturing - Bangalore
International footprint through our India Investment
  • Expansion of manufaction capacity
  • Offers alternative source of manufacture as required
  • Low cost base offers competitive advantage in Africa
  • Distribution capability by sea/air freight
  • Accreditation: South Africa (MCC), UK (MHRA), Australia (TGA), France (ANSES), Tanzania (TFDA), Kenya (PPB), Ghana (FDB), Namabia (NMRC), Uganda (UNDA), Ethiopia (DACAE) and Romania (RNAMMD)